Our Regulatory Affairs Committee remains dedicated to driving regulatory excellence, ultimately enhancing patient access to medical devices.

The committee will focus on:

• Regulatory Convergence: Striving for harmonisation across international markets.
• Regulatory Reliance: Leveraging global efforts for increased speed to markets.
• Regulatory Agility: Advocating flexibility for emerging innovative technologies.

We will accomplish this through:

• Predictive Regulatory Intelligence to stay ahead of regulatory developments.
• Strategic Advocacy to empower informed decision-making.
• Regulatory Capacity Building to modernise capabilities and equip future-ready leaders.